<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03429049</url>
  </required_header>
  <id_info>
    <org_study_id>CNTX-4975i-OA-301</org_study_id>
    <nct_id>NCT03429049</nct_id>
  </id_info>
  <brief_title>A Clinical Study to Test Efficacy and Safety of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centrexion Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centrexion Therapeutics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase 3, randomized, double-blind, placebo-controlled, single injection, 52-week
      study to evaluate the efficacy and safety of CNTX-4975-05 in subjects with chronic,
      moderate-to-severe osteoarthritis knee pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 24, 2018</start_date>
  <completion_date type="Anticipated">February 29, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Index Knee Pain</measure>
    <time_frame>Baseline at Week 12</time_frame>
    <description>Change in the average pain in the index knee with walking over the previous 24 hours using the numeric pain rating scale (NPRS) (0-10).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area Under the Curve (AUC) Change in Average Pain in the Index Knee</measure>
    <time_frame>Baseline through Week 12</time_frame>
    <description>AUC calculated on change in the average pain with walking in the index knee over the previous 24 hours, using the NPRS (0-10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Average Function in the Index Knee</measure>
    <time_frame>Baseline through Week 12</time_frame>
    <description>Change in the average function in the index knee, using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) C function subscale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC Change in the Average Pain in the Index Knee</measure>
    <time_frame>Baseline through Week 26</time_frame>
    <description>AUC calculated in the average pain in the index knee with walking over the previous 24 hours, using the NPRS (0-10), in subject.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Average Pain in the Index Knee with Walking</measure>
    <time_frame>Baseline through Week 26</time_frame>
    <description>Change in the average pain in the index knee with walking over the past 24 hours, using the NPRS (0-10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Average Pain in the Index Knee</measure>
    <time_frame>Baseline through Week 52</time_frame>
    <description>Change in the average pain in the index knee, using the WOMAC A pain subscale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Average Stiffness in the Index Knee</measure>
    <time_frame>Baseline through Week 52</time_frame>
    <description>Change in the average stiffness in the index knee, using the WOMAC B stiffness subscale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change (PGIC) for Index Knee Pain</measure>
    <time_frame>At Each Study Visit through Week 52</time_frame>
    <description>Rating of the index knee pain compared to Baseline using the PGIC scale (1-7) where 1 = very much improved and 7 = very much worse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life (QOL) - SF-36 Health Survey</measure>
    <time_frame>Baseline through Week 52</time_frame>
    <description>Change in the QOL as measured by the SF-36 Health Survey.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in QOL - EQ-5D-5L</measure>
    <time_frame>Baseline through Week 52</time_frame>
    <description>Change in QOL as measured by the EQ-5D-5L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Average Pain in the Index Knee</measure>
    <time_frame>Baseline through Weeks 38 and 52</time_frame>
    <description>Change in the average pain in the index knee with walking over the previous 24 hours, using the NPRS (0-10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Average Function in the Index Knee</measure>
    <time_frame>Baseline through Week 52</time_frame>
    <description>Change in the average function in the index knee, using the WOMAC C function subscale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Durability of Efficacy of a Single Intra-Articular (IA) Injection</measure>
    <time_frame>Baseline to the return of Baseline (NPRS pain with walking)</time_frame>
    <description>Durability of efficacy of a single IA injection of CNTX-4975-05, as measured by the time from Baseline to the return of baseline pain with walking as measured by NPRS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Responder Analysis</measure>
    <time_frame>Baseline through Week 12</time_frame>
    <description>Percent of patients with ≥ 30%, 50%, 70%, and 90% reduction in pain with walking (NPRS 0-10).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">325</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single intra-articular 1.0 mg Placebo Injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CNTX-4975-05</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single intra-articular 1.0 mg CNTX-4975-05 (trans-capsaicin) injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CNTX-4975-05 (trans-capsaicin)</intervention_name>
    <description>Receiving CNTX-4975-05 injection</description>
    <arm_group_label>CNTX-4975-05</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Receiving Placebo injection</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Male or female subjects between 40 and 95 years of age (inclusive) at the time of the
             Screening Visit with the ability to comply with answering the electronic diary using
             the study-provided tablet computers.

          -  Confirmation of osteoarthritis (OA) of the knee.

          -  Confirmation of OA of the index knee.

          -  Moderate to severe pain in the index knee associated with OA must be stable for a
             minimum of 6 months prior to Screening, as assessed by the investigator.

          -  BMI ≤45 kg/m^2.

          -  Must have failed 2 or more prior therapies.

          -  Females not of childbearing potential, defined as post-menopausal for at least 1 year,
             or surgically sterile, or practicing one of the following medically acceptable methods
             of birth control throughout the study period.

        Key Exclusion Criteria:

          -  Joint replacement surgery of the index knee at any time, or open surgery of the index
             knee in the past 24 months.

          -  Prior arthroscopic surgery of the index knee within 6 months of Screening.

          -  Any painful conditions of the index knee due to joint disease other than OA.

          -  Periarticular pain from any cause.

          -  Pain in the non-index knee that is &gt;3 numeric pain rating scale (NPRS) (0-10) when
             walking or at rest.

          -  Other chronic pain anywhere in the body that requires the use of analgesic
             medications.

          -  Instability of the index knee.

          -  Misalignment (&gt;10 degrees varus or valgus) of the index knee on standing.

          -  Documented history of neuropathic arthropathy or finding of bony fragmentation in the
             index knee with imaging.

          -  Physical/ occupational/ chiropractic therapy for the lower extremities or acupuncture
             for the lower extremities within 30 days of Screening, or need for such therapy during
             the study.

          -  Plans to have surgery, other invasive procedures, or IA injections while participating
             in the study.

          -  Has used topical capsaicin on the index knee within 90 days of Screening.

          -  Current use of opioids for any condition other than for OA of the index knee.

          -  Corticosteroid injection into the index knee within 90 days of Screening.

          -  Received IA viscosupplementation (eg, Synvisc®, Hyalgan®) within 90 days of Screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randall M. Stevens, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Centrexion Therapeutics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Manager</last_name>
    <phone>617-837-6911</phone>
    <email>info@centrexion.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Orthopaedic Center - Research</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cahaba Research, Inc</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Coastal Clinical Research, Inc</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Noble Clinical Research, LLC</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Orange County Research Institute</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Core Healthcare Group</name>
      <address>
        <city>Cerritos</city>
        <state>California</state>
        <zip>90703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Biosolutions Clinical Research Center</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Associates Research Group</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Encompass Clinical Research</name>
      <address>
        <city>Spring Valley</city>
        <state>California</state>
        <zip>91978</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tampa Bay Medical Research, Inc</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Avail Clinical Research, LLC</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>M&amp;M Medical Center, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33185</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sensible Healthcare, LLC</name>
      <address>
        <city>Ocoee</city>
        <state>Florida</state>
        <zip>34761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jewett Orthopaedic</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Drug Studies America</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Georgia Institute for Clinical Research, LLC</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Atlanta Orthopaedic Institute, LLC</name>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MediSphere Medical Research Center, LLC</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mid-American PolyClinic</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tristan Medical Enterprises PC, dba</name>
      <address>
        <city>North Attleboro</city>
        <state>Massachusetts</state>
        <zip>02760</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Research Associates, Inc</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <zip>49686</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research Consortium</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89119</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hassman Research Institute</name>
      <address>
        <city>Berlin</city>
        <state>New Jersey</state>
        <zip>08009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bone Joint &amp; Spine Surgeons, Inc</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tekton Research, Inc</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78745</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Metroplex Clinical Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Investigations of Texas</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ortho Virginia</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charlottesville Medical Research Center, LLC</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22911</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2018</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

